Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer

Romana Moench, Tanja Grimmig, Vinicius Kannen, Sudipta Tripathi, Marc Faber, Eva-Maria Moll, Anil Chandraker, Reinhard Lissner, Christoph-Thomas Germer, Ana Maria Waaga-Gasser (Corresponding Author), Martin Gasser (Corresponding Author)

Research output: Contribution to journalArticle

19 Citations (Scopus)
4 Downloads (Pure)

Abstract

Platelet-derived growth factor (PDGF) and signaling via its receptors plays a crucial role in tumor cell proliferation and thus may represent an attractive target besides VEGF/EGFR-based antibody therapies. In this study we analyzed the influence of PDGF in colorectal cancer. PDGF was expressed intensively in early and even more intensively in late stage primary CRCs. Like VEGF, PDGF enhanced human colon cancer proliferation, and increased oxidative glycolytic activity, and activated HIF1α and c-Myc in vitro. PDGF activated the PI3K/Akt/mTOR pathway while leaving MAPK signaling untouched. Further dissection showed that inhibition of Akt strongly impeded cancer cell growth while inhibition of PI3K did not. MAPK analysis suggested an inhibitory crosstalk between both pathways, thus explaining the different effects of the Akt and PI3K inhibitors on cancer cell proliferation. PDGF stimulates colon cancer cell proliferation, and prevents inhibitor induced apoptosis, resulting in tumor growth. Therefore inhibition of PDGF signaling seems to be a promising target in colorectal cancer therapy. However, due to the multifaceted nature of the intracellular PDGF signaling, careful intervention strategies are needed when looking into specific signaling pathways like PI3K/Akt/mTOR and MAPK.

Original languageEnglish
Pages (from-to)68749-68767
Number of pages19
JournalOncotarget
Volume7
Issue number42
DOIs
Publication statusPublished - 8 Sep 2016

Keywords

  • PDGF
  • colorectal cancer
  • PI3K/Akt/mTOR
  • MAPK pathway
  • glucose metabolism

Fingerprint Dive into the research topics of 'Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Moench, R., Grimmig, T., Kannen, V., Tripathi, S., Faber, M., Moll, E-M., Chandraker, A., Lissner, R., Germer, C-T., Waaga-Gasser, A. M., & Gasser, M. (2016). Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer. Oncotarget, 7(42), 68749-68767. https://doi.org/10.18632/oncotarget.11899